why choose us

First received: April 24, 2023

Clinical Trial: A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Moderate to Severe Asthma

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Brief Summary: The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Read more